Skip to main content

MARSHALL WACE, LLP

Position in AVXL — Anavex Life Sciences Corp.

CIK 1318757 LONDON, X0

Position in AVXL

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,287,855
+$639,259 QoQ
Shares Held
419,497
+130.3% QoQ
Ownership
0.453%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
14 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in AVXL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $2,766,756,129 across 280 Biotechnology names. AVXL ranks #180 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AVXL

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,287,855 419,497
2025-12-31 $648,596 182,190
2025-09-30 $1,621,490 182,190
2025-06-30 $1,679,791 182,190
2025-03-31 $1,563,189 182,190
2024-12-31 $1,515,617 141,119
2024-06-30 $166,061 39,351
2023-09-30 $1,022,310 156,078
2023-06-30 $91,860 11,299
2023-03-31 $408,789 47,700
2022-12-31 $324,062 34,996
2022-06-30 $4,240,596 423,636
2022-03-31 $558,356 45,358
2021-03-31 $2,438,150 163,087